 | • レポートコード：MRC2-11QY02532 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗けいれん薬のグローバル市場について調査・分析したレポートです。種類別（てんかん、線維筋痛症、片頭痛、神経因性疼痛、双極性障害、不安神経症、境界性人格障害）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗けいれん薬の競争状況、市場シェア ・世界の抗けいれん薬市場：種類別市場規模 2015年-2020年（てんかん、線維筋痛症、片頭痛、神経因性疼痛、双極性障害、不安神経症、境界性人格障害） ・世界の抗けいれん薬市場：種類別市場規模予測 2021年-2026年（てんかん、線維筋痛症、片頭痛、神経因性疼痛、双極性障害、不安神経症、境界性人格障害） ・世界の抗けいれん薬市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅ケア） ・世界の抗けいれん薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅ケア） ・北米の抗けいれん薬市場分析：米国、カナダ ・ヨーロッパの抗けいれん薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗けいれん薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗けいれん薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗けいれん薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson (J&J)、Novartis AG、UCB Group、GlaxoSmithKline plc.、Pfizer Inc.、Abbott Laboratories、Cephalon Inc.、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The Anticonvulsants are the diverse group of the pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder. They seem to act as mood stabilizers, and for the treatment of neuropathic pain. Anticonvulsants suppress the rapid and excessive firing of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain.
Anticonvulsant drugs are primarily developed for the treatment of epilepsy, a neurological condition that affects around the 50 million people worldwide. They reduce seizure frequency by suppressing neuronal excitability via various molecular targets in the synapse, including voltage-gated ion channels, voltage-gated GABAA (γ-aminobutyric acid type A) receptors and glutamate receptors.
Market Analysis and Insights: Global Anticonvulsants Market
The global Anticonvulsants market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anticonvulsants Scope and Market Size
Anticonvulsants market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticonvulsants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anticonvulsants market is segmented into
Epilepsy
Fibromyalgia
Migraine
Neuropathic pain
Bipolar disorder
Anxiety
Borderline personality disorder
Segment by Application, the Anticonvulsants market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Anticonvulsants market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anticonvulsants market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anticonvulsants Market Share Analysis
Anticonvulsants market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticonvulsants business, the date to enter into the Anticonvulsants market, Anticonvulsants product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson (J&J)
Novartis AG
UCB Group
GlaxoSmithKline plc.
Pfizer Inc.
Abbott Laboratories
Cephalon Inc.
Takeda
1 Study Coverage
1.1 Anticonvulsants Product Introduction
1.2 Market Segments
1.3 Key Anticonvulsants Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anticonvulsants Market Size Growth Rate by Type
1.4.2 Epilepsy
1.4.3 Fibromyalgia
1.4.4 Migraine
1.4.5 Neuropathic pain
1.4.6 Bipolar disorder
1.4.7 Anxiety
1.4.8 Borderline personality disorder
1.5 Market by Application
1.5.1 Global Anticonvulsants Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anticonvulsants Market Size, Estimates and Forecasts
2.1.1 Global Anticonvulsants Revenue 2015-2026
2.1.2 Global Anticonvulsants Sales 2015-2026
2.2 Global Anticonvulsants, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anticonvulsants Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anticonvulsants Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anticonvulsants Competitor Landscape by Players
3.1 Anticonvulsants Sales by Manufacturers
3.1.1 Anticonvulsants Sales by Manufacturers (2015-2020)
3.1.2 Anticonvulsants Sales Market Share by Manufacturers (2015-2020)
3.2 Anticonvulsants Revenue by Manufacturers
3.2.1 Anticonvulsants Revenue by Manufacturers (2015-2020)
3.2.2 Anticonvulsants Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anticonvulsants Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anticonvulsants Revenue in 2019
3.2.5 Global Anticonvulsants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anticonvulsants Price by Manufacturers
3.4 Anticonvulsants Manufacturing Base Distribution, Product Types
3.4.1 Anticonvulsants Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticonvulsants Product Type
3.4.3 Date of International Manufacturers Enter into Anticonvulsants Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anticonvulsants Market Size by Type (2015-2020)
4.1.1 Global Anticonvulsants Sales by Type (2015-2020)
4.1.2 Global Anticonvulsants Revenue by Type (2015-2020)
4.1.3 Anticonvulsants Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anticonvulsants Market Size Forecast by Type (2021-2026)
4.2.1 Global Anticonvulsants Sales Forecast by Type (2021-2026)
4.2.2 Global Anticonvulsants Revenue Forecast by Type (2021-2026)
4.2.3 Anticonvulsants Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anticonvulsants Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anticonvulsants Market Size by Application (2015-2020)
5.1.1 Global Anticonvulsants Sales by Application (2015-2020)
5.1.2 Global Anticonvulsants Revenue by Application (2015-2020)
5.1.3 Anticonvulsants Price by Application (2015-2020)
5.2 Anticonvulsants Market Size Forecast by Application (2021-2026)
5.2.1 Global Anticonvulsants Sales Forecast by Application (2021-2026)
5.2.2 Global Anticonvulsants Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticonvulsants Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anticonvulsants by Country
6.1.1 North America Anticonvulsants Sales by Country
6.1.2 North America Anticonvulsants Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anticonvulsants Market Facts & Figures by Type
6.3 North America Anticonvulsants Market Facts & Figures by Application
7 Europe
7.1 Europe Anticonvulsants by Country
7.1.1 Europe Anticonvulsants Sales by Country
7.1.2 Europe Anticonvulsants Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anticonvulsants Market Facts & Figures by Type
7.3 Europe Anticonvulsants Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anticonvulsants by Region
8.1.1 Asia Pacific Anticonvulsants Sales by Region
8.1.2 Asia Pacific Anticonvulsants Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anticonvulsants Market Facts & Figures by Type
8.3 Asia Pacific Anticonvulsants Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anticonvulsants by Country
9.1.1 Latin America Anticonvulsants Sales by Country
9.1.2 Latin America Anticonvulsants Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anticonvulsants Market Facts & Figures by Type
9.3 Central & South America Anticonvulsants Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anticonvulsants by Country
10.1.1 Middle East and Africa Anticonvulsants Sales by Country
10.1.2 Middle East and Africa Anticonvulsants Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anticonvulsants Market Facts & Figures by Type
10.3 Middle East and Africa Anticonvulsants Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson (J&J)
11.1.1 Johnson & Johnson (J&J) Corporation Information
11.1.2 Johnson & Johnson (J&J) Description and Business Overview
11.1.3 Johnson & Johnson (J&J) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson (J&J) Anticonvulsants Products Offered
11.1.5 Johnson & Johnson (J&J) Related Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description and Business Overview
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Anticonvulsants Products Offered
11.2.5 Novartis AG Related Developments
11.3 UCB Group
11.3.1 UCB Group Corporation Information
11.3.2 UCB Group Description and Business Overview
11.3.3 UCB Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 UCB Group Anticonvulsants Products Offered
11.3.5 UCB Group Related Developments
11.4 GlaxoSmithKline plc.
11.4.1 GlaxoSmithKline plc. Corporation Information
11.4.2 GlaxoSmithKline plc. Description and Business Overview
11.4.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc. Anticonvulsants Products Offered
11.4.5 GlaxoSmithKline plc. Related Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Corporation Information
11.5.2 Pfizer Inc. Description and Business Overview
11.5.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Inc. Anticonvulsants Products Offered
11.5.5 Pfizer Inc. Related Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Corporation Information
11.6.2 Abbott Laboratories Description and Business Overview
11.6.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Abbott Laboratories Anticonvulsants Products Offered
11.6.5 Abbott Laboratories Related Developments
11.7 Cephalon Inc.
11.7.1 Cephalon Inc. Corporation Information
11.7.2 Cephalon Inc. Description and Business Overview
11.7.3 Cephalon Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cephalon Inc. Anticonvulsants Products Offered
11.7.5 Cephalon Inc. Related Developments
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Description and Business Overview
11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Takeda Anticonvulsants Products Offered
11.8.5 Takeda Related Developments
11.1 Johnson & Johnson (J&J)
11.1.1 Johnson & Johnson (J&J) Corporation Information
11.1.2 Johnson & Johnson (J&J) Description and Business Overview
11.1.3 Johnson & Johnson (J&J) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson (J&J) Anticonvulsants Products Offered
11.1.5 Johnson & Johnson (J&J) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anticonvulsants Market Estimates and Projections by Region
12.1.1 Global Anticonvulsants Sales Forecast by Regions 2021-2026
12.1.2 Global Anticonvulsants Revenue Forecast by Regions 2021-2026
12.2 North America Anticonvulsants Market Size Forecast (2021-2026)
12.2.1 North America: Anticonvulsants Sales Forecast (2021-2026)
12.2.2 North America: Anticonvulsants Revenue Forecast (2021-2026)
12.2.3 North America: Anticonvulsants Market Size Forecast by Country (2021-2026)
12.3 Europe Anticonvulsants Market Size Forecast (2021-2026)
12.3.1 Europe: Anticonvulsants Sales Forecast (2021-2026)
12.3.2 Europe: Anticonvulsants Revenue Forecast (2021-2026)
12.3.3 Europe: Anticonvulsants Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anticonvulsants Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anticonvulsants Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anticonvulsants Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anticonvulsants Market Size Forecast by Region (2021-2026)
12.5 Latin America Anticonvulsants Market Size Forecast (2021-2026)
12.5.1 Latin America: Anticonvulsants Sales Forecast (2021-2026)
12.5.2 Latin America: Anticonvulsants Revenue Forecast (2021-2026)
12.5.3 Latin America: Anticonvulsants Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anticonvulsants Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anticonvulsants Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anticonvulsants Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anticonvulsants Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anticonvulsants Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticonvulsants Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anticonvulsants Market Segments
Table 2. Ranking of Global Top Anticonvulsants Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anticonvulsants Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Epilepsy
Table 5. Major Manufacturers of Fibromyalgia
Table 6. Major Manufacturers of Migraine
Table 7. Major Manufacturers of Neuropathic pain
Table 8. Major Manufacturers of Bipolar disorder
Table 9. Major Manufacturers of Anxiety
Table 10. Major Manufacturers of Borderline personality disorder
Table 11. Global Anticonvulsants Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Anticonvulsants Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Anticonvulsants Sales by Regions 2015-2020 (K Units)
Table 14. Global Anticonvulsants Sales Market Share by Regions (2015-2020)
Table 15. Global Anticonvulsants Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Anticonvulsants Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Anticonvulsants Sales Share by Manufacturers (2015-2020)
Table 18. Global Anticonvulsants Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Anticonvulsants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticonvulsants as of 2019)
Table 20. Anticonvulsants Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Anticonvulsants Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Anticonvulsants Price (2015-2020) (USD/Unit)
Table 23. Anticonvulsants Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anticonvulsants Product Type
Table 25. Date of International Manufacturers Enter into Anticonvulsants Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 28. Global Anticonvulsants Sales Share by Type (2015-2020)
Table 29. Global Anticonvulsants Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Anticonvulsants Revenue Share by Type (2015-2020)
Table 31. Anticonvulsants Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 33. Global Anticonvulsants Sales Share by Application (2015-2020)
Table 34. North America Anticonvulsants Sales by Country (2015-2020) (K Units)
Table 35. North America Anticonvulsants Sales Market Share by Country (2015-2020)
Table 36. North America Anticonvulsants Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Anticonvulsants Revenue Market Share by Country (2015-2020)
Table 38. North America Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 39. North America Anticonvulsants Sales Market Share by Type (2015-2020)
Table 40. North America Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 41. North America Anticonvulsants Sales Market Share by Application (2015-2020)
Table 42. Europe Anticonvulsants Sales by Country (2015-2020) (K Units)
Table 43. Europe Anticonvulsants Sales Market Share by Country (2015-2020)
Table 44. Europe Anticonvulsants Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Anticonvulsants Revenue Market Share by Country (2015-2020)
Table 46. Europe Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 47. Europe Anticonvulsants Sales Market Share by Type (2015-2020)
Table 48. Europe Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 49. Europe Anticonvulsants Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Anticonvulsants Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Anticonvulsants Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Anticonvulsants Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Anticonvulsants Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Anticonvulsants Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Anticonvulsants Sales Market Share by Application (2015-2020)
Table 58. Latin America Anticonvulsants Sales by Country (2015-2020) (K Units)
Table 59. Latin America Anticonvulsants Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Anticonvulsants Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Anticonvulsants Revenue Market Share by Country (2015-2020)
Table 62. Latin America Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 63. Latin America Anticonvulsants Sales Market Share by Type (2015-2020)
Table 64. Latin America Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 65. Latin America Anticonvulsants Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Anticonvulsants Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Anticonvulsants Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anticonvulsants Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Anticonvulsants Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Anticonvulsants Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Anticonvulsants Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Anticonvulsants Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Anticonvulsants Sales Market Share by Application (2015-2020)
Table 74. Johnson & Johnson (J&J) Corporation Information
Table 75. Johnson & Johnson (J&J) Description and Major Businesses
Table 76. Johnson & Johnson (J&J) Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Johnson & Johnson (J&J) Product
Table 78. Johnson & Johnson (J&J) Recent Development
Table 79. Novartis AG Corporation Information
Table 80. Novartis AG Description and Major Businesses
Table 81. Novartis AG Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novartis AG Product
Table 83. Novartis AG Recent Development
Table 84. UCB Group Corporation Information
Table 85. UCB Group Description and Major Businesses
Table 86. UCB Group Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. UCB Group Product
Table 88. UCB Group Recent Development
Table 89. GlaxoSmithKline plc. Corporation Information
Table 90. GlaxoSmithKline plc. Description and Major Businesses
Table 91. GlaxoSmithKline plc. Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. GlaxoSmithKline plc. Product
Table 93. GlaxoSmithKline plc. Recent Development
Table 94. Pfizer Inc. Corporation Information
Table 95. Pfizer Inc. Description and Major Businesses
Table 96. Pfizer Inc. Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Pfizer Inc. Product
Table 98. Pfizer Inc. Recent Development
Table 99. Abbott Laboratories Corporation Information
Table 100. Abbott Laboratories Description and Major Businesses
Table 101. Abbott Laboratories Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Abbott Laboratories Product
Table 103. Abbott Laboratories Recent Development
Table 104. Cephalon Inc. Corporation Information
Table 105. Cephalon Inc. Description and Major Businesses
Table 106. Cephalon Inc. Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Cephalon Inc. Product
Table 108. Cephalon Inc. Recent Development
Table 109. Takeda Corporation Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Anticonvulsants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Takeda Product
Table 113. Takeda Recent Development
Table 114. Global Anticonvulsants Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Anticonvulsants Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Anticonvulsants Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Anticonvulsants Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Anticonvulsants Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Anticonvulsants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Anticonvulsants Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Anticonvulsants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Anticonvulsants Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Anticonvulsants Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Anticonvulsants Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Anticonvulsants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Anticonvulsants Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Anticonvulsants Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Anticonvulsants Players
Table 132. Anticonvulsants Customers List
Table 133. Anticonvulsants Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticonvulsants Product Picture
Figure 2. Global Anticonvulsants Sales Market Share by Type in 2020 & 2026
Figure 3. Epilepsy Product Picture
Figure 4. Fibromyalgia Product Picture
Figure 5. Migraine Product Picture
Figure 6. Neuropathic pain Product Picture
Figure 7. Bipolar disorder Product Picture
Figure 8. Anxiety Product Picture
Figure 9. Borderline personality disorder Product Picture
Figure 10. Global Anticonvulsants Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Home Care
Figure 14. Anticonvulsants Report Years Considered
Figure 15. Global Anticonvulsants Market Size 2015-2026 (US$ Million)
Figure 16. Global Anticonvulsants Sales 2015-2026 (K Units)
Figure 17. Global Anticonvulsants Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Anticonvulsants Sales Market Share by Region (2015-2020)
Figure 19. Global Anticonvulsants Sales Market Share by Region in 2019
Figure 20. Global Anticonvulsants Revenue Market Share by Region (2015-2020)
Figure 21. Global Anticonvulsants Revenue Market Share by Region in 2019
Figure 22. Global Anticonvulsants Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Anticonvulsants Revenue in 2019
Figure 24. Anticonvulsants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Anticonvulsants Sales Market Share by Type (2015-2020)
Figure 26. Global Anticonvulsants Sales Market Share by Type in 2019
Figure 27. Global Anticonvulsants Revenue Market Share by Type (2015-2020)
Figure 28. Global Anticonvulsants Revenue Market Share by Type in 2019
Figure 29. Global Anticonvulsants Market Share by Price Range (2015-2020)
Figure 30. Global Anticonvulsants Sales Market Share by Application (2015-2020)
Figure 31. Global Anticonvulsants Sales Market Share by Application in 2019
Figure 32. Global Anticonvulsants Revenue Market Share by Application (2015-2020)
Figure 33. Global Anticonvulsants Revenue Market Share by Application in 2019
Figure 34. North America Anticonvulsants Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Anticonvulsants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Anticonvulsants Sales Market Share by Country in 2019
Figure 37. North America Anticonvulsants Revenue Market Share by Country in 2019
Figure 38. U.S. Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Anticonvulsants Market Share by Type in 2019
Figure 43. North America Anticonvulsants Market Share by Application in 2019
Figure 44. Europe Anticonvulsants Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Anticonvulsants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Anticonvulsants Sales Market Share by Country in 2019
Figure 47. Europe Anticonvulsants Revenue Market Share by Country in 2019
Figure 48. Germany Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Anticonvulsants Market Share by Type in 2019
Figure 59. Europe Anticonvulsants Market Share by Application in 2019
Figure 60. Asia Pacific Anticonvulsants Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Anticonvulsants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Anticonvulsants Sales Market Share by Region in 2019
Figure 63. Asia Pacific Anticonvulsants Revenue Market Share by Region in 2019
Figure 64. China Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Anticonvulsants Market Share by Type in 2019
Figure 87. Asia Pacific Anticonvulsants Market Share by Application in 2019
Figure 88. Latin America Anticonvulsants Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Anticonvulsants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Anticonvulsants Sales Market Share by Country in 2019
Figure 91. Latin America Anticonvulsants Revenue Market Share by Country in 2019
Figure 92. Mexico Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Anticonvulsants Market Share by Type in 2019
Figure 99. Latin America Anticonvulsants Market Share by Application in 2019
Figure 100. Middle East and Africa Anticonvulsants Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Anticonvulsants Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Anticonvulsants Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Anticonvulsants Revenue Market Share by Country in 2019
Figure 104. Turkey Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Anticonvulsants Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Anticonvulsants Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Anticonvulsants Market Share by Type in 2019
Figure 111. Middle East and Africa Anticonvulsants Market Share by Application in 2019
Figure 112. North America Anticonvulsants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Anticonvulsants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Anticonvulsants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Anticonvulsants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Anticonvulsants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Anticonvulsants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Anticonvulsants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Anticonvulsants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Anticonvulsants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Anticonvulsants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
双極性障害治療の世界市場（～2026年） Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. Accord…- 慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- 疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pain Management Therapeutics Market The global Pain Management Therapeutics market size is projected to reach US$ 59160 million by 2026, from US$ 57740 million in 2020, at a CAGR of 2.3%% during 2021-2026. Global Pain Management Therapeutics Scope and Market Size…
- 過食症治療薬の世界市場（～2026年） Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusuall…